Insider · CIK 0001821605
Alka Chaubey
Files at BNGO (Bionano Genomics, Inc.). First filing -, latest -.
Alka Chaubey files SEC Form 4 as officer at BNGO (Bionano Genomics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Alka Chaubey has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | BNGO Bionano Genomics, Inc. | FTax withholding Common Stock | -24 | $1.30 | $31 | 620 | Jun 3, 2026 |
| Feb 17, 2026 | BNGO Bionano Genomics, Inc. | FTax withholding Common Stock | -18 | $1.10 | $20 | 644 | Feb 18, 2026 |
| Feb 2, 2026 | BNGO Bionano Genomics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +27,737 | $0.00 | $0 | 27,737 | Feb 4, 2026 |
| Sep 11, 2025 | BNGO Bionano Genomics, Inc. | FTax withholding Common Stock | -51 | $4.06 | $207 | 662 | Sep 12, 2025 |
| Jun 3, 2025 | BNGO Bionano Genomics, Inc. | FTax withholding Common Stock | -24 | $3.69 | $89 | 713 | Jun 3, 2025 |
| Mar 14, 2025 | BNGO Bionano Genomics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +6,966 | $0.00 | $0 | 6,966 | Mar 18, 2025 |
| Feb 15, 2025 | BNGO Bionano Genomics, Inc. | FTax withholding Common Stock | -18 | $5.73 | $103 | 737 | Feb 19, 2025 |
Questions about Alka Chaubey
Answered from the filings on this page, as of the latest one.
Is Alka Chaubey buying or selling?
Alka Chaubey has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Alka Chaubey's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Alka Chaubey has 0.
Where does Alka Chaubey file Form 4?
Alka Chaubey has filed Form 4 at BNGO (Bionano Genomics, Inc.) as CHIEF MEDICAL OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.